These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17675339)

  • 1. Resveratrol suppresses prostate cancer progression in transgenic mice.
    Harper CE; Patel BB; Wang J; Arabshahi A; Eltoum IA; Lamartiniere CA
    Carcinogenesis; 2007 Sep; 28(9):1946-53. PubMed ID: 17675339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
    Wang J; Eltoum IE; Lamartiniere CA
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):171-80. PubMed ID: 15149738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
    Mentor-Marcel R; Lamartiniere CA; Eltoum IE; Greenberg NM; Elgavish A
    Cancer Res; 2001 Sep; 61(18):6777-82. PubMed ID: 11559550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
    Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
    Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
    Raghow S; Hooshdaran MZ; Katiyar S; Steiner MS
    Cancer Res; 2002 Mar; 62(5):1370-6. PubMed ID: 11888907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
    Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model.
    Sargeant AM; Rengel RC; Kulp SK; Klein RD; Clinton SK; Wang YC; Chen CS
    Cancer Res; 2008 May; 68(10):3999-4009. PubMed ID: 18483287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
    Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
    Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.
    Harper CE; Cook LM; Patel BB; Wang J; Eltoum IA; Arabshahi A; Shirai T; Lamartiniere CA
    Prostate; 2009 Nov; 69(15):1668-82. PubMed ID: 19670229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
    Hsieh TC; Wu JM
    Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model.
    Seeni A; Takahashi S; Takeshita K; Tang M; Sugiura S; Sato SY; Shirai T
    Asian Pac J Cancer Prev; 2008; 9(1):7-14. PubMed ID: 18439064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
    Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.
    Shao TC; Li H; Ittmann M; Cunningham GR
    J Urol; 2007 Oct; 178(4 Pt 1):1521-7. PubMed ID: 17707058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.